Acutaas Chemicals Ltd · NSE:ACUTAAS
Acutaas Chemicals — Ami Organics — Q2 FY22 Earnings Presentation
32 slides from Acutaas Chemicals's earnings presentation, Oct 25, 2021
Slide 1: Regulation 30 filing cover letter
Ai Ami Organics Limited ( Formerly known as Ami Organics Pvt. lt d . ) CIN N o . : U24100GJ2007PLC051093 Registered Office & Manufacturing Facility :- Plot No. 440/4, 5, & 6, Road No. 82/A, G.I.D.C. Sachin, S u r a t - 394230. Dist. Surat, Gujarat, India. October 25, 2 0 2 1 To, To, The Li s t i n g
Slide 2: Investor Presentation October 2021
AMI O R G A N I C S LI M I T E D O C TO BER - 2 0 2 1 Investor Presentation 5 .9 Ami Organics Limited BSE: 543349 | NSE: AMIORG | WWW.AMIORGANICS.COM 1
Slide 3: AMI Organics
AMI Organics 01. A Specialty Chemicals Company… …Supporting innovations 02. as well as assisting Pharmaceuticals, Agrochemicals and Fine Chemical industry to improve the life of an ordinary person Our niche products, track record of working with innovators, high focus on R&D, leading market share in
Slide 4: Company Overview contents
AMI Organics ▪ Company Overview 01. A Specialty Chemicals Company… ▪ Our Journey …Supporting innovations ▪ Products and their Application 02. as well as assisting Pharmaceuticals, Agrochemicals and Fine Chemical industry to improve the life of an ordinary person ▪ Our Manufacturing Facilities Our ni
Slide 5: A Specialty Chemicals Company - Overview
A Specialty Chemicals Company - Overview Ao AMI ORGANICS LIMITED AMI Organics (AMI) is a research and development driven manufacturer of specialty chemicals with varied end usage and is focused on the development and manufacturing of advanced pharmaceutical intermediates (“Pharma Intermediates”) for
Slide 6: Our Journey
Our Journey Ao AMI ORGANICS LIMITED ▪ Obtained certifications for ISO 9001:2015 and ISO 14001:2015 ▪ Received second EIR from ▪ Established a tertiary ETP to USFDA for manufacturing facility at Sachin 5 become zero liquid discharge .£ plant ▪ Increased ▪ Commencement of a new ▪ Received recognition
Slide 7: Our Products and their Application
Our Products and their Application Ao AMI ORGANICS LIMITED Pharma Intermediates ▪ Our Company has an experience of over 15 years of developing, manufacturing Historical Business Performance and commercializing advanced pharma intermediates used for manufacturing API and NCE in India and overseas. We
Slide 8: Our Products and their Application (Cont'd)
Our Products and their Application (Cont’d) Pharma Intermediates – Strong and Diversified portfolio with robust market standing Therapy / API Key Pharma Intermediate(s) supplied by Ami Organics Global Market Share Disease Targeted ▪ 1-(3-Chloro Phenyl)4-(3-Chloro Propyl)Piperazine H Trazodone Antide
Slide 9: Our Products and their Application (Cont'd)
Our Products and their Application (Cont’d) Ao AMI ORGANICS LIMITED 4 Specialty Chemicals l ' ▪ Existing portfolio: Historical Business Performance KSM for Fine Chemicals/ Specialty Chemicals ▪ Recent acquisition: 166 Products (Rs Mn) In line with Company’s inorganic growth strategy of foraying furt
Slide 10: Our Manufacturing Facilities
Our Manufacturing Facilities… AMI ORGANICS LIMITED � 5.. Manufacturing Total Land Area Installed tp!8 Facilities Total (sq mtrs) 75,892 Capacity (MTPA) 6,060 Placeholder for warehouse picture Placeholder for facility picture Placeholder for facility picture Placeholder for facility picture Sachin Un
Slide 11: Superior R&D Capabilities
Superior R&D Capabilities AMI ORGANICS LIMITED R&D Expenditures ▪ R&D facility certified and approved ▪ 2,200 sq mtrs DSIR approved in-house R&D Rs. 24mn Rs. 86mn Rs. 65mn by DSIR of India. facility at Sachin supported by an ADL 4.0% ▪ Equipped with state-of-the-art ▪ 8 Process Patents filed in Indi
Slide 12: Strong and Long-term relations with Diversified Customers across Geographies
Strong and Long-term relations with Diversified Customers across Geographies Ao AMI ORGANICS LIMITED Clientele Revenue from Exports 5 - 3 • . Exports Revenue as % of Key Exports Destinations / 0 Revenue from Operations O R G A N I K E Europe 50% 46% 52% Israel Japan North America China D (Rs mn) 1,7
Slide 13: Our Leadership
Our Leadership AMI ORGANICS LIMITED Board of Directors Nareshkumar Patel Chetankumar Vaghasia Virendra Mishra Girikrishna Maniar Richa Goyal Hetal Gandhi Executive Chairman, MD Whole-time Director Whole-time Director Non-executive, Non-executive, Non-executive Independent Director Independent Direct
Slide 14: Aiding pharmaceuticals companies in bettering lives
AMI Organics 01. A Specialty chemicals company… ▪ Aiding pharmaceuticals companies in bettering lives …Supporting innovations 02. as well as assisting Pharmaceuticals, Agrochemicals and ▪ Supporting Agrochemicals Fine Chemical industry to improve the life of an ordinary person and Fine Chemicals Our
Slide 15: Aiding pharmaceuticals companies in bettering lives
Aiding pharmaceuticals companies in bettering lives Ao AMI ORGANICS LIMITED Currently ~90% of our revenue come from …with Global API industry estimated to grow by …whereas Key APIs for which Intermediates are products used in Pharmaceutical industry 6%; witnessing shift in production activity from m
Slide 16: Supporting Agrochemicals and Fine Chem companies in improving lives
Supporting Agrochemicals and Fine Chem companies in improving lives Our existing Chemicals segment supplies KSMs to Agrochemicals and Fine Chemicals company … KSMs Global KSM Market – Size and Growth India KSM Market – Size and Growth (USD Bn) (USD Bn) 40 8.0 CAGR 6.1% CAGR 10.6% CAGR 30 6.1% CAGR 4
Slide 17: Supporting Agrochem and Fine Chem companies in improving lives (Cont'd)
Supporting Agrochem and Fine Chem companies in improving lives(Cont’d) Ao AMI ORGANICS LIMITED …whereas our new acquired units manufactures preservatives along with some specialty chemicals such as salicylic acid Parabens Salicylic Acid Global Paraben Market – Global Paraben Market – Global Salicyli
Slide 18: AMI Organics
AMI Organics 01. A Specialty chemicals company… …Supporting innovations 02. as well as assisting Pharmaceuticals, Agrochemicals and Fine Chemical industry to improve the life of an ordinary person Our niche products, track record of working with innovators, high focus on R&D, leading market share in
Slide 19: Our competitive advantage
Our competitive advantage Niche Product Portfolio with strong ▪ Niche products with limited competition focused on Chronic disease market 1 market share ▪ Our key products holds more than 50% market share globally Successful track record of working ▪ Ami has established itself as a trusted and relia
Slide 20: AMI Organics
AMI Organics 01. A Specialty chemicals company… …Supporting innovations 02. as well as assisting Pharmaceuticals, Agrochemicals and Fine Chemical industry to improve the life of an ordinary person Our niche products, track record of working with innovators, high focus on R&D, leading market share in
Slide 21: Our Financial performance over the years
Our Financial performance over the years… Revenue from Operations(1) – Growth Trends (Rs Mn) FY19-21 CAGR: 22% 174% 17% 20% 3,406 3,011 ■ FY19 ■ FY20 ■ FY21 2,385 2,396 2,034 2,179 329 229 22 74 166 143 Pharma Intermediates Speciality Chemicals Others Total Revenue – by Business Verticals Revenue fr
Slide 22: Our Financial performance over the years
Our Financial performance over the years… AMI ORGANICS LIMITED EBITDA and EBITDA Margins (%) PAT and PAT Margins (%) (Rs Mn) (Rs Mn) - EBITDA (₹ Mn) EBITDA Margin (%) 23.5% - PAT (₹ Mn) PAT Margin (%) 900 25.0% 600 15.9% 18.0% CAGR:38% CAGR: 52% 800 700 17.6% -�---- 17.1% 802 20.0% 500 540 16.0% 14.
Slide 23: Financials for last three years
Financials for last three years Restated Summary Statement of Profit and Loss Restated Summary Statement of Assets and Liabilities Particulars (Rs. Mn) FY19 FY20 FY21 Particulars (Rs. Mn) FY19 FY20 FY21 I. ASSETS Revenue from Operations 2,385 2,396 3,406 NON-CURRENT ASSETS Other Income 4 28 14 Prope
Slide 24: Q2 & H1 FY22 Results
AMI Organics 01. A Specialty chemicals company… ▪ Management Commentary ▪ Q2 & H1FY22 Earnings …Supporting innovations Highlights 02. as well as assisting Pharmaceuticals, Agrochemicals and Fine Chemical industry to improve the life of an ordinary person ▪ Strong financial Our niche products, track
Slide 25: Management Commentary
Management Commentary AMI ORGANICS LIMITED “Before I discuss the results, I would like to thank all the shareholders Revenue for 0 for their confidence and trust in AMI Organics and its management H1FY22 . . which was visible in the 64x subscription for the IPO. Rs. 2,354 mn I am happy to report tha
Slide 26: Q2 & H1FY22 Earnings Highlights
Q2 & H1FY22 Earnings Highlights Financial Highlights ✓ Revenue for Q2FY22 grew by 34% YoY to Rs.1,223mn ✓ H1FY22 Revenue grew by 51% YoY to Rs. 2,354mn ✓ Revenue from newly acquired facilities was Rs. 395mn for the half year ✓ Gross margin for the half year was at 48% higher by 402 bps ✓ EBITDA for
Slide 27: Strong financial performance with margin expansion (Quarterly)
Strong financial performance with margin expansion (Quarterly) AMI ORGANICS LIMITED Revenue from Operations ■ Q2FY21 ■ Q2FY22 (Rs Mn) FY19-21 CAGR: 27% 136% -41% 34% 1,223 967 913 759 220 93 61 36 Advance Intermediates Chemicals Others Total EBITDA & EBITDA Margin PAT EPS (Rs Mn) (Rs Mn) 300 - 24.0%
Slide 28: Strong financial performance with margin expansion (half-yearly)
Strong financial performance with margin expansion (half-yearly) AMI ORGANICS LIMITED Revenue from Operations ■ H1FY21 ■ H1FY22 (Rs Mn) FY19-21 CAGR: 37% 234% 27% 51% 2,354 1,835 1,558 1,342 397 119 97 123 Advance Intermediates Chemicals Others Total EBITDA & EBITDA Margin PAT EPS (Rs Mn) (Rs Mn) -
Slide 29: P&L for Q2 and H1 FY22
P&L for Q2 and H1 FY22 Particulars (Rs. Mn) Q2FY22 Q2FY21 YoY Q1FY22 QoQ H1FY22 H1FY21 YoY Revenue from Operations 1,223 913 34.0% 1,131 8.1% 2,354 1,558 51.1% COGS 562 486 15.8% 644 -12.7% 1,206 861 40.1% Gross Profit 661 427 54.7% 487 35.6% 1,148 697 64.7% Gross Margin 54.0% 46.8% 43.1% 48.8% 44.7
Slide 30: Shareholder Information
Shareholder Information AMI Shareholding as on 30th September 2021 Share Information (as on 30th September 2021) NSE Ticker AMIORG BSE Ticker 543349 Market Cap (Rs. Cr) 4,747 Others Promoters % free-float 18.76% 41.9% 41.5% (Shares pledged – Nil) Free-float market cap (Rs. Cr) 877 Total Debt (Rs. Cr
Slide 31: Safe Harbor
Safe Harbor The Presentation is to provide the general background information about the Company’s activities as at the date of the Presentation. The information contained herein is for general information purposes only and based on estimates and should not be considered as a recommendation that any
Slide 32: Thank You
AMI O R G A N I C S L I M I T E D For more information please contact: Ami Organics Limited Ekta Srivastava, Company Secretary & Compliance Officer cs@amiorganics.com Christensen Advisory Rahul Thakur / Shreya Krishnan rthakur@christensenir.com / Skrishnan@christensenir.com Thank You © 2020 Ami Orga